Neuropathic Pain & Cannibinoids-2009 Oct

Neuropathic Pain & Cannibinoids-2009 Oct

In 2009, Cannabinoids as pharmacotherapies for neuropathic pain: nerve injury, diabetes, chemotherapeutic treatment, human immunodeficiency virus, multiple sclerosis, and herpes zoster infection is considered. Background: review of clinical and preclinical literature evaluating CB1, CB2, THC You can read the full article here =>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2755639/

Pain Management Study for Elderly-2018 Mar

In 2018, Studied the safety and efficacy of medical cannabis in elderly treatments of 2736 patients.  Background: A prospective study that included all patients above 65 years of age who received medical cannabis from January 2015 to October 2017. You can read the full article here => https://multiplesclerosisnewstoday.com/2018/02/20/medical-cannabis-treats-chronic-pain-older-multiple-sclerosis-other-patients-report/?utm_content=buffer09fa0&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer

MS Symptoms & Cannabis Study-2012 Nov

In 2012, A 12 week study using Cannabis Extract for muscle stiffness associated with Multiple Sclerosis Patients aged 18-64 years  Background: Double blind, placebo controlled, with a 2 week dose titration phase from 5 mg to a maximum of 25 mg of THC daily and a 10 week maintenance phase. You can read the full article here => https://www.researchgate.net/publication/229082908_MUltiple_Sclerosis_and_Extract_of_Cannabis_results_of_the_MUSEC_trial

MS Neuropathic Pain Clinical Study-2007 Dec

In 2007, Uncontrolled patient trial of THC/cannabidiol for neuropathic pain associated with multiple sclerosis with a 2-year extension trial. Background: 64 males completed the randomized trial and 63 entered the open-label extension. age, range, 27–71 years. You can read the full article here => http://www.clinicaltherapeutics.com/article/S0149-2918(07)00294-9/

Neuropathic Pain – 2012 Dec

In 2012, a double-blind, placebo-controlled, crossover study evaluating the analgesic efficacy of vaporized cannabis with 39 patients showed Low Dose Vaporized Cannabis Significantly Improves Neuropathic Pain Background: Thirty-nine subjects participated in 111 six-hour study sessions. You can read the full article here =>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566631/